Clinical Study of the Third Dose Immunization Schedule of COVID-19 Inactivated Vaccine, (Vero Cells) in Adults Aged 18 Years and Above (6 Months After Two Doses)
Clinical trial NCT05216484 · UNKNOWN
Trial details
- NCT number
- NCT05216484
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-18
- Primary completion
- 2022-10-30
- Enrollment
- 480
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.